BRPI0515256A - processo para preparação de piperidinas n-(arilmetil substituìdo)-4-substituìdas-4-(metila dissubstituìda) e intermediários - Google Patents

processo para preparação de piperidinas n-(arilmetil substituìdo)-4-substituìdas-4-(metila dissubstituìda) e intermediários

Info

Publication number
BRPI0515256A
BRPI0515256A BRPI0515256-9A BRPI0515256A BRPI0515256A BR PI0515256 A BRPI0515256 A BR PI0515256A BR PI0515256 A BRPI0515256 A BR PI0515256A BR PI0515256 A BRPI0515256 A BR PI0515256A
Authority
BR
Brazil
Prior art keywords
substituted
preparing
intermediates
piperidines
arylmethyl
Prior art date
Application number
BRPI0515256-9A
Other languages
English (en)
Inventor
Jaidev Goudar
David S Rosen
Walter H Yeager
Guozhi Wang
Qun Zhang
Russell Patera
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of BRPI0515256A publication Critical patent/BRPI0515256A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCESSO PARA PREPARAçãO DE PIPERIDINAS N-(ARILMETIL SUBSTITUìDO)-4-SUBSTITUìDAS-4(METILA DISSUBSTITUìDA) E INTERMEDIáRIOS A presente invenção refere-se a um processo aperfeiçoado que é descrito para preparação de uma piperidina N-(arilmetil substituído)-4-substituída-4-(metila dissubstituída) da fórmula (I):onde R¬ 1¬ e R¬ 2¬ são independentemente selecionadas do grupo consistindo em halogênio, CF~ 3~, OCF~ 3~, OCHF~ 2~, OCF~ 2~CHF~ 2~ e SF~ 5~; e Z e B são independentemente selecionados do grupo consistindo em CH e N; bem como processos para preparação de intermediários úteis no processo geral.
BRPI0515256-9A 2004-09-13 2005-09-12 processo para preparação de piperidinas n-(arilmetil substituìdo)-4-substituìdas-4-(metila dissubstituìda) e intermediários BRPI0515256A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60953304P 2004-09-13 2004-09-13
PCT/US2005/032279 WO2006031674A1 (en) 2004-09-13 2005-09-12 Process for preparing n-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates

Publications (1)

Publication Number Publication Date
BRPI0515256A true BRPI0515256A (pt) 2008-07-15

Family

ID=36060365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515256-9A BRPI0515256A (pt) 2004-09-13 2005-09-12 processo para preparação de piperidinas n-(arilmetil substituìdo)-4-substituìdas-4-(metila dissubstituìda) e intermediários

Country Status (10)

Country Link
US (1) US20080039631A1 (pt)
EP (1) EP1791828A1 (pt)
JP (1) JP2008512488A (pt)
KR (1) KR20070106678A (pt)
CN (1) CN101018777A (pt)
AR (1) AR051082A1 (pt)
BR (1) BRPI0515256A (pt)
MX (1) MX2007002913A (pt)
TW (1) TW200621749A (pt)
WO (1) WO2006031674A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003860A (es) * 2003-10-10 2006-07-03 Fmc Corp Azaciclos n-sustituidos.

Also Published As

Publication number Publication date
US20080039631A1 (en) 2008-02-14
KR20070106678A (ko) 2007-11-05
MX2007002913A (es) 2009-02-12
EP1791828A1 (en) 2007-06-06
CN101018777A (zh) 2007-08-15
WO2006031674A1 (en) 2006-03-23
AR051082A1 (es) 2006-12-20
TW200621749A (en) 2006-07-01
JP2008512488A (ja) 2008-04-24

Similar Documents

Publication Publication Date Title
BRPI0514644A (pt) composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna
BRPI0506843A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BRPI0510410A (pt) compostos orgánicos
BR0309659A (pt) Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
BRPI0206433B8 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0407967A (pt) processo de uma etapa para a preparação de derivados anticonvulsivantes
DE502004012095D1 (de) Verfahren zum herstellen von 2-dihalogenacyl-3-amino-acryls ureestern und 3-dihalogenmethyl-pyrazol-4-carbons ureestern
EA200901529A1 (ru) Производные арилоазол-2-илцианоэтиламина, способ их получения и способ их применения
AR041297A1 (es) Derivados de 4-pirrolidino- fenil- bencil eter
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE480525T1 (de) Neues verfahren zur synthese von 2- aminooxazolverbindungen
ECSP099269A (es) Compuestos de fenilurea como inhibidores de epóxido hidrolasa soluble
DK1831239T5 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
RS51858B (en) 4 - [(3-FLUOROPHENOXY) PHENYLMETHYL] PIPERIDINE METANSULPHONATE: ITS USES, PROCESSING METHODS AND PHARMACEUTICAL COMPOSITIONS
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
EA200600061A1 (ru) Бензамиды 4-(аминометил) пиперидина как 5нт-антагонисты
UY29498A1 (es) Derivados de aminoácidos
BRPI0411308A8 (pt) Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
ATE542810T1 (de) Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase
BRPI0515256A (pt) processo para preparação de piperidinas n-(arilmetil substituìdo)-4-substituìdas-4-(metila dissubstituìda) e intermediários
DE602004015418D1 (de) Rekombinantes mva und verfahren zur erzeugung davon
EA200801400A1 (ru) Новые производные индолизина, способ их получения и терапевтические композиции на их основе
BRPI0514313A (pt) processo para sintetizar um composto, e, composto

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired